MX2023004637A - Drug supply system. - Google Patents

Drug supply system.

Info

Publication number
MX2023004637A
MX2023004637A MX2023004637A MX2023004637A MX2023004637A MX 2023004637 A MX2023004637 A MX 2023004637A MX 2023004637 A MX2023004637 A MX 2023004637A MX 2023004637 A MX2023004637 A MX 2023004637A MX 2023004637 A MX2023004637 A MX 2023004637A
Authority
MX
Mexico
Prior art keywords
supply system
drug supply
active pharmaceutical
pharmaceutical ingredients
component
Prior art date
Application number
MX2023004637A
Other languages
Spanish (es)
Inventor
Prof Dr Achim Schneeberger
Klaus Kühne
Helmut Kerschbaumer
Srdan Vasic
Original Assignee
Laxxon Medical Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laxxon Medical Ag filed Critical Laxxon Medical Ag
Priority to MX2023004637A priority Critical patent/MX2023004637A/en
Publication of MX2023004637A publication Critical patent/MX2023004637A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a drug supply system, mainly by oral administration for controlled administration of one or more active pharmaceutical ingredients, including a soluble base body fluid component and a separating soluble component with therapeutically effective active pharmaceutical ingredients.
MX2023004637A 2020-07-13 2020-07-13 Drug supply system. MX2023004637A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2023004637A MX2023004637A (en) 2020-07-13 2020-07-13 Drug supply system.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2023004637A MX2023004637A (en) 2020-07-13 2020-07-13 Drug supply system.

Publications (1)

Publication Number Publication Date
MX2023004637A true MX2023004637A (en) 2023-05-12

Family

ID=90140557

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023004637A MX2023004637A (en) 2020-07-13 2020-07-13 Drug supply system.

Country Status (1)

Country Link
MX (1) MX2023004637A (en)

Similar Documents

Publication Publication Date Title
SG11201808167VA (en) Prodrugs of cytotoxic active agents having enzymatically cleavable groups
MX2020007625A (en) Mtor inhibitor, pharmaceutical composition and use thereof.
MX2023008716A (en) Camptothecin compound, preparation method therefor, and application thereof.
AU2018231044A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
MX2021009199A (en) Bi-ligand drug conjugate and use thereof.
MX2021008247A (en) Combination of dextromethorphan and bupropion for treating depression.
WO2015020943A3 (en) Digestive enzyme composition suitable for enteral administration
NZ605469A (en) Nalbuphine-based formulations and uses thereof
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
BR112012030641A2 (en) methods and compositions for oral pharmaceutical therapy
AU2018282104A1 (en) Use of vibegron to treat overactive bladder
MX2023013840A (en) Piperazine derivative and use thereof in medicine.
MX2015009546A (en) Increased dosage of efavirenz for the treatment of cancer.
NZ751972A (en) Treatment of prurigo nodularis
ZA201905212B (en) Rescue treatment of post operative nausea and vomiting
MX2023003675A (en) Hsd17b13 inhibitors and uses thereof.
MX2023004637A (en) Drug supply system.
MX2017013633A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles.
MX2020006886A (en) Drug delivery system.
MX2023012007A (en) Transdermal drug delivery systems for administration of a therapeutically effective amount of lenalidomide and other immunomodulatory agents.
MX2023011297A (en) Abhd6 antagonist.
MX2023005763A (en) Compositions and methods for deep dermal drug delivery.
MX2017013643A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix.
MX2023001014A (en) Pharmaceutical compositions comprising venglustat.
MX2018005298A (en) Dosage regimen for a phosphatidylinositol 3-kinase inhibitor.